However, the use of ML, both alone and in combination with chemotherapeutic drugs, exhibited strong synergistic effects in the treatment of BRAF-mutated A-2058 and WM 266-4 melanoma cell lines, as well as in U-87 and U-118 glioblastoma cells [15,16]. The gene discussed is BRAF; the disease is glioblastoma.